Kraig Biocraft Laboratories, Inc.
KBLB
$0.08
$0.000.00%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -726.10K | -600.00K | -851.70K | -433.20K | -1.61M |
Total Depreciation and Amortization | 36.90K | 5.70K | 19.80K | 59.30K | 6.70K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 4.50K | -58.90K | 54.10K | -113.30K | 886.00K |
Change in Net Operating Assets | 241.70K | 218.70K | 265.30K | 160.90K | 202.70K |
Cash from Operations | -443.10K | -434.50K | -512.50K | -326.30K | -510.80K |
Capital Expenditure | -3.80K | -- | -4.20K | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 147.20K | -- | -- | -- | -- |
Cash from Investing | 143.50K | -- | -4.20K | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | 0.00 | -5.20K | -15.00K |
Issuance of Common Stock | 856.40K | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -168.20K | 158.20K | -- | -- | -- |
Cash from Financing | 688.10K | 158.20K | 0.00 | -5.20K | -15.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 388.50K | -276.30K | -516.80K | -331.50K | -525.80K |